Top

Published in:

01-03-2004 | Editorial

Persisting differences in truth telling throughout the world

Author: Antonella Surbone

Published in: Supportive Care in Cancer | Issue 3/2004

Excerpt

This issue of our journal presents two articles [13, 24] that deal with different aspects of truth telling to the cancer patient. The article by Culha Atesci et al. [13] examines the psychiatric distress in 117 patients from Turkey admitted for chemotherapy of early stage cancers. The authors find a higher level of distress among those patients who were aware of their cancer diagnosis—an observation contradicted by many Western studies [14]. The authors acknowledge that other patient-related factors and disease and treatment variables, as well as social and environmental elements, may have contributed to the higher psychiatric morbidity. …

Anderlik MR, Pentz RD, Hess KR (2000) Revisiting the truth telling debate: a study of disclosure practices at a major cancer center. J Clin Ethics 11:251–259PubMed

Annas GJ (1994) Informed consent, cancer, and truth in prognosis (1994) N Engl J Med 330:223–225CrossRefPubMed

Authors, various. In: Surbone A, Zwitter M (eds) (1997) Communication with the cancer patient. Information and truth. Ann NY Acad Sci 809

Back A, Baile W (2003) Communication skills: myths, realities and new developments. Commentary. J Supp Oncol 1:169–171

Back AL, Arnold RM, Tulsky JA et al (2003) Teaching communication skills to medical oncology fellows. J Clin Oncol 21:2433–2436CrossRefPubMed

Baier A (1994) Moral prejudices: essays on ethics. Harvard University Press, Cambridge

Baile WF, Buckman R, Lenzi R et al (2000) SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5:302–311PubMed

Blackhall L (1995) Ethnicity and attitudes toward patient autonomy. JAMA 274:820–825PubMed

Buckman R (1992) How to break bad news: a guide for health care professionals. Johns Hopkins University Press, Baltimore

10.

Carrese J, Rhodes L (1995) Western bioethics on the Navajo reservation: benefit or harm? JAMA 274:826–829PubMed

11.

Costantini-Ferrando MF, Foley KM, Rapkin BD (1998) Communicating with patients about advanced cancer (letter). JAMA 280:1403CrossRef

12.

Coyle N, Sculco MA (2003) Communication and the patient/physician relationship: a phenomenological inquiry. J Supp Oncol 1:206–215

13.

Culha Atesci F, Baltalarli B, Oguzhanoglu K et al (2004) Psychiatric morbidity among cancer patients and awareness of illness. Support Care Cancer

14.

Fallowfield L (1997) Truth sometime hurts, but deceit hurts more. In: Communication with the cancer patient. Surbone A, Zwitter M (eds) Ann NY Acad Sci 809:525–536

15.

Fallowfield L, Jenkins V, Farewell V et al (2002) Efficacy of a cancer research UK communication skills training model for oncologists: a randomized controlled trial. Lancet 359:650–656CrossRefPubMed

16.

Grassi L, Giraldi T, Messina EG et al (2000) Physicians’ attitudes to and problems with truth-telling to cancer patients. Support Care Cancer 8:40–45PubMed

17.

Hall P, Stone G, Fiset VJ (1998) Palliative care: how can we meet the needs of our multicultural communities? J Pall Care 14:46–49

18.

Higginson IJ, Costantini M (2002) Communication in end-of-life cancer care: A comparison of team assessment in three European countries. J Clin Oncol 20:3674–3682CrossRefPubMed

19.

Kagawa-Singer M, Blackhall LJ (2001) Negotiating cross-cultural issues at the end of life. JAMA 286:2993–3001CrossRefPubMed

20.

Kodish E, Post GP (1995) Oncology and hope. J Clin Oncol 13:1817–1822PubMed

21.

Lamont EB, Christakis NA (2003) Complexities in prognostication in advanced cancer “to help them live their lives the way they want to”. JAMA 2901:98–102

22.

Gostin LO (1995) Informed consent, cultural sensitivity and respect for persons. JAMA 274:844–845CrossRefPubMed

23.

Maguire P (1990) Can communication skills be taught? Br J Hosp Med 43:215–216PubMed

24.

Mystakidou K, Parpa E, Tsilika E et al (2004) Cancer information disclosure in different cultural contexts. Support Care Cancer

25.

Olweny C (1994) The ethics and conduct of cross-cultural research in developing countries. Psycho-Oncol 3:11–20

26.

Pellegrino ED (1987) Altruism, self–interest and medical ethics. JAMA 258:1939–1940CrossRefPubMed

27.

Pellegrino, ED, Thomasma DC (1981) For the Patient’s Good. The Restoration of Beneficence in Health Care. Oxford University Press, New York

28.

Schapira L (2003) Communication skill training in clinical oncology: the ASCO position reviewed and an optimistic personal perspective. Crit Rev Oncol Hematol 46:25–31CrossRefPubMed

29.

Seibert PS, Stridh-Igo P, Zimmermann CG (2002) A checklist to facilitate cultural awareness and sensitivity. J Med Ethics 28:143–146CrossRefPubMed

30.

Seo M, Tamura K, Shijo H et al (2000) Telling the diagnosis to cancer patients in Japan: attitudes and perceptions of patients, physicians and nurses. Palliat Med 14:105–110PubMed

31.

Smith TJ, Swisher K (1998) Telling the truth about terminal cancer (editorial). JAMA 279:1746–748CrossRefPubMed

32.

Authors, various (2002) In: Baider L, Cooper CL, Kaplan De-Nour A (eds) Cancer and the family. Wiley & Sons

33.

Surbone A (2000) Truth telling. In: Cohen-Almagor R (ed), Medical ethics at the dawn of the 21st century. Ann NY Acad Sci 913:52–62PubMed

34.

Surbone A (2003) The quandary of cultural diversity. Guest editorial. J Pall Care 19:3–4

35.

Surbone A, Lowenstein J (2003) Asymmetry in the relationship between patients and d physicians. J Clin Ethics 14:3PubMed

36.

Weeks JC, Cook EF, O’Day SJ et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279:1709–1714CrossRefPubMed

Title: Persisting differences in truth telling throughout the world
Author: Antonella Surbone
Publication date: 01-03-2004
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 3/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-003-0579-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2004

Support group programme for relatives of terminally ill cancer patients

Endoscopic and surgical palliation of gastrointestinal tumors

March 2004

Symptom masquerade: understanding the meaning of symptoms

March 2004

Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal follow-up

Keynote webinar | Spotlight on antibody–drug conjugates in cancer